Impact of COVID-19 in patients with autoimmune bullous
diseases: Report from an international registry.

J 2023

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.

MEIJER, Joost M; Hanan RASHID; Styliani VERGADI; Emiliano ANTIGA; Pamela VEZZOLI et al.

Základní údaje

Originální název

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.

Autoři

Vydání

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, HOBOKEN, WILEY, 2023, 0926-9959

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30216 Dermatology and venereal diseases

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 8.500

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/23:00132899

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

COVID-19; autoimmune bullous diseases

Štítky

14110125, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 31. 1. 2024 09:05, Mgr. Tereza Miškechová

Anotace

V originále

For autoimmune bullous diseases (AIBD) such as bullous pemphigoid (BP) and pemphigus an increased risk of COVID-19 infection and mortality was reported, with oral prednisolone (dose ≥10 mg/day) and treatment of rituximab being a risk factor. A population-based cohort study showed an increased COVID-19 associated mortality in patients with BP, but not in patients with pemphigus vulgaris. Here, we provide the findings of an international registry for health care providers about COVID-19 infection in patients with AIBD, reporting on timing and clinical presentation of COVID-19 infection, AIBD disease activity and outcome.

Citovat

MEIJER, Joost M; Hanan RASHID; Styliani VERGADI; Emiliano ANTIGA; Pamela VEZZOLI; Riccardo BALESTRI; Aikaterini PATSATSI; Soner UZUN; Dusan SKILJEVIC; Hana JEDLIČKOVÁ; Lucia VOJTĚCHOVÁ; Alberto CORRÀ; Alessandra PONZIANI; Claudia GÜNTHER; Giuseppe CIANCHINI; Matthias SCHEFZYK; Angelo MARZANO; Di Zenzo GIOVANNI; Iakov SHIMANOVICH; Janet FAIRLEY; Jose M MASCARÓ; Marzia CAPRONI; Roberto MAGLIE; Enno SCHMIDT a Barbara HORVÁTH. Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. HOBOKEN: WILEY, 2023, roč. 37, č. 10, s. "e1189"-"e1191", 3 s. ISSN 0926-9959. Dostupné z: https://doi.org/10.1111/jdv.19242.

@article{2358800,
   author = {Meijer, Joost M and Rashid, Hanan and Vergadi, Styliani and Antiga, Emiliano and Vezzoli, Pamela and Balestri, Riccardo and Patsatsi, Aikaterini and Uzun, Soner and Skiljevic, Dusan and Jedličková, Hana and Vojtěchová, Lucia and Corrà, Alberto and Ponziani, Alessandra and Günther, Claudia and Cianchini, Giuseppe and Schefzyk, Matthias and Marzano, Angelo and Giovanni, Di Zenzo and Shimanovich, Iakov and Fairley, Janet and Mascaró, Jose M and Caproni, Marzia and Maglie, Roberto and Schmidt, Enno and Horváth, Barbara},
   article_location = {HOBOKEN},
   article_number = {10},
   doi = {https://doi.org/10.1111/jdv.19242},
   keywords = {COVID-19; autoimmune bullous diseases},
   language = {eng},
   issn = {0926-9959},
   journal = {JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY},
   title = {Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.},
   url = {https://onlinelibrary.wiley.com/doi/10.1111/jdv.19242},
   volume = {37},
   year = {2023}
}

TY  - JOUR
ID  - 2358800
AU  - Meijer, Joost M - Rashid, Hanan - Vergadi, Styliani - Antiga, Emiliano - Vezzoli, Pamela - Balestri, Riccardo - Patsatsi, Aikaterini - Uzun, Soner - Skiljevic, Dusan - Jedličková, Hana - Vojtěchová, Lucia - Corrà, Alberto - Ponziani, Alessandra - Günther, Claudia - Cianchini, Giuseppe - Schefzyk, Matthias - Marzano, Angelo - Giovanni, Di Zenzo - Shimanovich, Iakov - Fairley, Janet - Mascaró, Jose M - Caproni, Marzia - Maglie, Roberto - Schmidt, Enno - Horváth, Barbara
PY  - 2023
TI  - Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.
JF  - JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
VL  - 37
IS  - 10
SP  - "e1189"-"e1191"
EP  - "e1189"-"e1191"
PB  - WILEY
SN  - 09269959
KW  - COVID-19
KW  - autoimmune bullous diseases
UR  - https://onlinelibrary.wiley.com/doi/10.1111/jdv.19242
N2  - For autoimmune bullous diseases (AIBD) such as bullous pemphigoid (BP) and pemphigus an increased risk of COVID-19 infection and mortality was reported, with oral prednisolone (dose ≥10 mg/day) and treatment of rituximab being a risk factor. A population-based cohort study showed an increased COVID-19 associated mortality in patients with BP, but not in patients with pemphigus vulgaris. Here, we provide the findings of an international registry for health care providers about COVID-19 infection in patients with AIBD, reporting on timing and clinical presentation of COVID-19 infection, AIBD disease activity and outcome.
ER  -

MEIJER, Joost M; Hanan RASHID; Styliani VERGADI; Emiliano ANTIGA; Pamela VEZZOLI; Riccardo BALESTRI; Aikaterini PATSATSI; Soner UZUN; Dusan SKILJEVIC; Hana JEDLIČKOVÁ; Lucia VOJTĚCHOVÁ; Alberto CORRÀ; Alessandra PONZIANI; Claudia GÜNTHER; Giuseppe CIANCHINI; Matthias SCHEFZYK; Angelo MARZANO; Di Zenzo GIOVANNI; Iakov SHIMANOVICH; Janet FAIRLEY; Jose M MASCARÓ; Marzia CAPRONI; Roberto MAGLIE; Enno SCHMIDT a Barbara HORVÁTH. Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry. \textit{JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY}. HOBOKEN: WILEY, 2023, roč.~37, č.~10, s.~''e1189''-''e1191'', 3 s. ISSN~0926-9959. Dostupné z: https://doi.org/10.1111/jdv.19242.

Přehled o publikaci